E-Newsletter - Summer 2017

Recent Alliance protocol activations
 

Alliance A171603: Feasibility of an electronic geriatric assessment (eGA) for older adults with cancer

Overview: This limited access Alliance trial will determine the feasibility of an electronic generiatric assessment (eGA) for older adults with cancer in academic and community oncology clinics. Feasiblity will be determined by percentage of patients able to complete the self-reported section of the eGA and have a completed healthcare professional section. Participating sites include Memorial Sloan Kettering Cancer Center, Gundersen Lutheran Medical Center, UNC Lineberger Comprehensive Cancer Center, Queens Hospital Center, City of Hope Cancer Comprehensive Cancer Center, Saint Joseph Mercy Health System, University of Alabama, Birmingham, Spartanburg Regional Health Services District, and University of Wisconsin Hospital and Clinics.

Study Chair: Emily Guerard, MD
E-mail: eguerard@medicine.wisc.edu
Activated: 07/14/17

Alliance A191402CD: Testing decision aids to improve prostate cancer decisions for minority men

Overview: This Alliance randomized phase III trial will study how well decision aids work in improving knowledge in patients with prostate cancer. Decision aids may improve patients' knowledge of their condition and options for treatment, and may also help when talking with their doctor.

Study Chair: Jon Tilburt, MD
E-mail: tilburt.jon@mayo.edu
Activated: 07/14/17
Link: https://clinicaltrials.gov/ct2/show/NCT03182998

Alliance A041501: A phase III trial to evaluate the efficacy of the addition of inotuzumab ozogamicin (a conjugated anti-CD22 monoclonal antibody) to frontline therapy in young adults (ages 18-39 years) with newly diagnosed precursor B-Cell ALL

Overview: This Alliance randomized phase III trial will study how well pulmonary rehabilitation before surgery works compared to standard care in improving recovery in patients with non-small cell lung cancer and chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation in the form of exercise and breathing training may help improve quality of life and recovery by reducing the length of stay and pulmonary complications in patients with COPD who are undergoing surgery for lung cancer.

Study Chair: Daniel DeAngelo, MD
E-mail: ddeangelo@partners.org
Activated: 06/01/17
Link: https://clinicaltrials.gov/ct2/show/NCT03150693

Alliance A221502: Pulmonary rehabilitation before lung cancer resection

Overview: This Alliance randomized phase III trial will study how well pulmonary rehabilitation before surgery works compared to standard care in improving recovery in patients with non-small cell lung cancer and chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation in the form of exercise and breathing training may help improve quality of life and recovery by reducing the length of stay and pulmonary complications in patients with COPD who are undergoing surgery for lung cancer.

Study Chair: Roberto Benzo, MD
E-mail: benzo.roberto@mayo.edu
Activated: 03/15/17
Link: https://clinicaltrials.gov/ct2/show/NCT02887521

 

For other articles in the Summer issue of the Alliance E-News newsletter, see below.